N-Terminal Fragment Brain Natriuretic Protein clinical trials
23 active trials name this biomarker in their eligibility criteria. Describe your situation to see which ones look like a fit.
- Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
- The STOP-MED CTRCD Trial
- Exercise Training in Transthyretin Cardiac Amyloidosis
- Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
- Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
- A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
- A Study of LY3971297 in Participants With Heart Failure
- A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
- A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System
- NORM-HF Pivotal Study
- In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm
- Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
- Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF
- Muscle Blood Flow Regulation in HFpEF
- The GUARDIAN Trial - Vasopressor Sub-Study
- Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
- The PEERLESS II Study
- Study of JK07 in Patients With Chronic Heart Failure
- Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that name “N-Terminal Fragment Brain Natriuretic Protein” in their eligibility criteria, at any level. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.